DashboardAll companies
Run this on your own research
Healthcare · Biotechnology

Ligachem Biosciences Inc.

141080KRX₩61,500−₩2,500 (−3.91%)Market closed

Price Chart

Daily

Key facts

Market Cap
₩2.28T
P/E
−30.1x
P/B
4.41x
ROE
−13.2%

Ligachem Biosciences Inc.

Healthcare · Biotechnology · FY 2025

Ligachem Biosciences Inc. is a prominent player in the biopharmaceutical industry, primarily engaged in the discovery and development of innovative therapeutic solutions. The company focuses on leveraging cutting-edge research and advanced biotechnology to address unmet medical needs globally. Through its strategic R&D initiatives, Ligachem Biosciences Inc. develops a diverse pipeline of drug candidates aimed at treating a wide range of diseases, including rare genetic disorders, cancer, and infectious diseases. The company operates in collaboration with academic institutions, healthcare providers, and pharmaceutical companies to accelerate the process of bringing new treatments to market. By prioritizing the integration of scientific expertise and technology, Ligachem Biosciences Inc. plays a critical role in advancing healthcare and improving patient outcomes worldwide. Its commitment to innovation and collaboration distinguishes it within the competitive landscape of biotechnology, contributing significantly to the industry's growth and evolution.

CEO
김용주
Employees
170

Company Statistics

Valuation

P/E
−30.1x
P/B
4.41x
P/S
15.80x
EV/EBITDA
−26.6x
P/FCF
−17.1x

Margins

Gross
89.0%
EBITDA
−57.8%
Operating
−75.2%
Pre-Tax
−66.3%
Net
−64.7%

Returns

ROA
−12.7%
ROE
−13.2%
ROIC
−12.9%

Growth (CAGR)

Rev 3Yr
61.8%
Rev 5Yr
23.4%
Op Inc 3Yr
—
Net Inc 3Yr
—

Financial Health

Cash & Cash Equivalents
₩98.65B
Net Debt
₩62.04B
Debt/Equity
29.7%
Interest Cov
—

Profile

Revenue
₩141.55B
Shares Out
37.0M
Public markets · Korea, US, Japanalpha-lenz.com · Core by Treasurer
Ligachem Biosciences Inc. (141080) Stock Forecast 2026 ₩61,500 — Price, Financials & Analyst Targets | AlphaLenz